Capitala Group Exits Investment in Optio Rx
November 11, 2020
Capitala Group announced it has exited its senior secured debt and minority equity investment in Optio Rx, a national owner and operator of specialty compounding pharmacies. The original investment was made in partnership with Cold Bore Capital and funded Optio Rx's roll-up of specialty pharmacies serving fertility, veterinary, dermatology, hormone replacement and hospice markets.
- Targets
- Optio Rx
- Sellers
- Capitala Group
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Pouschine Cook Leads Investment in Curexa Pharmacy
December 4, 2021
Healthcare Services
Pouschine Cook Capital Management led a growth investment in Curexa Pharmacy, a PCAB-accredited 503A compounding pharmacy that partners with direct-to-consumer telemedicine brands. Institutional co-investors included ORIX Corporation USA’s Private Equity Solutions group and Hexagon; First Horizon Bank provided senior credit facilities and management completed a meaningful rollover to support continued scaling of Curexa’s digital and pharmacy infrastructure.
-
One Equity Partners Completes Strategic Investment in InfuCare Rx
January 12, 2022
Healthcare Services
One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.
-
Cyprium Partners Invests in OneroRx
January 25, 2024
Healthcare Services
Cyprium Partners provided subordinated debt and minority common equity to OneroRx Inc., an integrated pharmacy services provider headquartered in West Des Moines, Iowa. The growth capital will support OneroRx’s acquisition-driven expansion across the Midwest—where the company operates roughly 65 locations and fills millions of prescriptions annually—and marks Cyprium’s 100th platform investment.
-
Osceola Capital-Backed Revelation Pharma Acquires Everwell Specialty Pharmacy
March 23, 2021
Healthcare Services
Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.
-
SK Capital Partners Acquires Apotex Pharmaceutical Holdings
April 3, 2023
Pharmaceuticals
An affiliate of funds advised by SK Capital Partners has completed the acquisition of Apotex Pharmaceutical Holdings Inc. SK Capital appointed Allan Oberman as President and CEO as it looks to transform Apotex into a Canadian-based global health company; Apotex employs nearly 8,000 people and sells affordable medicines in over 100 countries.
-
Main Street Capital Recapitalizes I-deal Optics
December 22, 2021
Consumer Products
Main Street Capital Holdings, LLC completed a recapitalization of its portfolio company I-deal Optics, Inc. in partnership with the company's management to provide liquidity and support continued growth. I-deal Optics is a wholesale supplier of prescription eyeglass frames with national reach and a diverse brand portfolio.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.